Interstitial Lung Diseases research hub

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

This study looks at a new medicine, nerandomilast, for people with lung scarring (fibrosis) linked to rheumatic diseases. It aims to see if nerandomilast improves lung function when standard treatments haven't helped. Participants take tablets for several months, with regular check-ups.